The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases
AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer's, Parkinson’s, and related neurodegenerative diseases. The "AD/PD™ Session Spotlight" series is an AI-powered podcast that brings you key insights from the AD/PD™ Conference, with expert presentations and research discussions transformed into concise, easy-to-digest episodes.
Join us as we uncover the latest innovations, explore groundbreaking research, and discuss the future of neurodegenerative disease treatments and therapies.
- Update frequency
- every 14 days
- Average duration
- 17 minutes
- Episodes
- 11
- Years Active
- 2025
Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LRRK2, and GBA Pathologies, AD/PD™ Session Spotlight
In this episode, we spotlight Forum Discussion 5 from the AD/PD™ 2025 International Conference — “Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LR…
Pathogenic Mechanisms of Familial AD and Emerging Therapeutic Developments, AD/PD™ Session Spotlight
In this episode, we highlight Plenary Lecture 05 from the AD/PD™ 2025 International Conference — “Pathogenic Mechanisms of Familial AD and Emerging Therapeutic Developments.”
Chaired by Prof. Manfred …
Translational Drug Development in AD: Promising Strategies for Treatment and Disease Modification, AD/PD™ Session Spotlight
In this episode, we unpack the key insights from Forum Discussion 04 at the AD/PD™ 2025 International Conference — “Translational Drug Development in AD (Phase I–III) and Relevance for Treatment and …
Treatment of DLB and PDD: Status and New Developments, AD/PD™ Session Spotlight
In this episode, we feature Plenary Lecture 04 from the AD/PD™ 2025 International Conference — the Eric N. Birch Memorial Lecture, titled “Treatment of DLB and PDD: Status and New Developments.”
Chair…
Improving the Therapeutic Potential of Immunotherapies in Alzheimer’s Disease, AD/PD™ Session Spotlight
In this episode, we spotlight Forum Discussion 03 from the AD/PD™ 2025 International Conference: “Improving the Therapeutic Potential of Immunotherapies in AD – Can Novel Strategies or Next Generatio…
GLP-1R Agonist Effects in the Brain: Exploring Semaglutide and Neuroinflammation, AD/PD™ Session Spotlight
In this episode, we explore Plenary Lecture 2 from the AD/PD™ 2025 International Conference: “GLP-1R Agonist Effects in Brain.”
Moderated by Dr. Cynthia Lemere (USA) and Dr. Henrietta Nielsen (Sweden)…
Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and AI in MCI & AD, AD/PD™ Session Spotlight
In this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — Forum Discussion 2, "Integrating Blood-Based, CSF and Imaging Biomarkers Wi…
The Alzheimer's Disease Drug Development Pipeline: Observations and Implications, AD/PD™ Session Spotlight
In this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™ 2025, titled "The Alzheimer's Disease Drug Development Pipeline: Observations and Implications," delivered by Dr.…
Plasma Biomarkers for Dementias in the Era of Disease-Modifying Therapies, AD/PD™ Session Spotlight
In episode 2 of AD/PD™ Session Spotlight, we feature Plenary Lecture 3, the Don Price Memorial Lecture, titled "Plasma Biomarkers for Dementias in the Era of Disease-Modifying Therapies," presented b…
Varying Regulatory Philosophies and AD Approval Priorities, AD/PD™ Session Spotlight
In this episode of AD/PD™ Session Spotlight, we delve into Forum Discussion 1, "Varying Regulatory Philosophies and AD Approval Priorities – USA, EU, Asia, and Other Parts of the World," a dynamic ex…
Welcome to the AD/PD™ Session Spotlight
Welcome to AD/PD™ Session Spotlight, an official podcast series by AD/PD™. The podcast will discuss the latest cutting-edge science and real-world clinical impact in Alzheimer’s, Parkinson’s, and rel…